Immunology to Change Lives

At BRI, innovation isn't just a buzzword — it's a commitment to making life better for people living with immune system diseases. Innovation means not just looking for better treatments, but asking exactly why a disease happens, and how we can stop it before it starts. It's about looking for answers in unexpected places and building new tools to solve long-standing problems. It means bringing together experts across different specialties to do together what they cannot do alone. It's about thinking differently, trying new approaches, and asking bold questions; all in the pursuit of our vision of a healthy immune system for everyone.

We invite you to join us at Immunology To Change Lives on Thursday, October 24, 2024, where you’ll have the opportunity to learn about the impact of innovation from BRI President Jane Buckner, MD, and panelists, hear firsthand about advances led by our scientists, and discover how we’re using immunology to change lives. The evening will include ample time for audience Q&A with our investigators; bites and beverages will be served.

RSVP today

Seats for this event are limited; please RSVP at your earliest convenience.

Full-Width Sunset Club 2023-11

Event Details

Immunology To Change Lives will take place on Thursday, October 24, 2024, from 5:30-8 p.m. at the Sunset Club (1021 University St., Seattle, WA 98101). Space for this event is limited; please RSVP to reserve your seat.
RSVP today

Featured speakers

At the event, a panel of BRI scientists led by Adam Lacy-Hulbert, PhD, director of BRI's Center for Systems Immunology, will discuss our latest work in:

  • Examining the role of the gut microbiome in immune system disease development and treatment.
  • Studying how environmental exposures like the sun, viruses, chemicals and air quality affect the development and progression of autoimmune diseases.
  • Creating lab-grown beta cells to study type 1 diabetes.
  • Discovering more about the function of an autoantibody present in people with lupus, which may lead to improved diagnosis and treatment of the disease.
  • Screening for autoimmune diseases like type 1 diabetes, rheumatoid arthritis and celiac disease. 
1-3RowPic Bio Jane Buckner

Jane Buckner, MD

Dr. Buckner has served as president of BRI since 2016 and has been with the institute as an investigator since 1999. She is a practicing rheumatologist at Virginia Mason Medical Center and is renowned for her research in translational immunology, combining genetics, immunology and clinical medicine to advance the understanding of the causes of autoimmune disease.
Learn more
1or3RowPic Bio Allyson Byrd

Allyson Byrd, PhD

Dr. Byrd’s research is focused on generating and analyzing large clinical datasets to gain new insights into how the bacteria present in the gut — called the gut microbiome — influence the development of immune system diseases like cancer, as well as a person’s response to treatment for these conditions.
Learn more
1-3RowPic Bio Jessica Hamerman

Jessica Hamerman, PhD

Dr. Hamerman’s research is focused on better understanding how the human body responds to infection as well as why autoimmune diseases like lupus develop. She aims to provide new insights into how inflammation driven by the immune system in these circumstances can be better controlled.
Learn more
1or3RowPic Bio Eddie James

Eddie James, PhD

Dr. James’ research is focused on better understanding how the immune cells involved in autoimmune diseases like type 1 diabetes and rheumatoid arthritis contribute to disease development, activity and progression. Through doing so, he hopes to identify potential new approaches to treatment for people living with or at risk for these conditions.
Learn more
1or3RowPic Bio Adam Lacy Hulbert

Adam Lacy-Hulbert, PhD

As director of BRI’s Center for Systems Immunology, Dr. Lacy-Hulbert leads our scientists in using mathematics and computer analysis to examine cells, molecules and processes in the immune system, as well as in collecting, processing and examining data from studies across BRI and around the world.
Learn more
1or3RowPic Bio Cate Speake

Cate Speake, PhD

Much of Dr. Speake’s research is focused on identifying ways to delay or prevent the development of type 1 diabetes and translating scientific findings from the laboratory to the clinic. She also coleads a study aiming to better understand how the exposome — the sum total of everything a person is exposed to over their lifetime — influences the development and progression of autoimmune disease.
Learn more

News

News Image - King 5 News
News

Why are Autoimmune Diseases So Prevalent in Women?

Read More
Adam Lacy-Hulbert
News

Benaroya Research Institute’s Dr. Adam Lacy-Hulbert Receives Puget Sound Business Journal Researcher of the Year Award

Read More
First row, left to right: Jessica Hamerman, PhD; Adam Lacy-Hulbert, PhD; Peter Morawski, PhD; Jane Buckner, MD. Second row, left to right: Eddie James, PhD; John Ray, PhD; Estelle Bettelli, PhD; James Lord, MD, PhD
Press Release

Benaroya Research Institute Awarded More Than $14 Million Across 11 Grants To Help Predict, Prevent, Reverse and Cure Immune System Diseases

Read More

Blog Stories

Left: Jessica Hamerman, PhD; right: John Ray, PhD
October 23, 2024

Innovation Fund Spotlight: Single-Cell CRISPR Screening To Explore Genetics and Autoimmune Diseases

Together, Jessica Hamerman, PhD, and John Ray, PhD, are exploring the genetic roots of autoimmune disease using single-cell CRISPR screening.
Read Article
Left: Eddie James, PhD; right: Caroline Stefani, PhD
October 23, 2024

Innovation Fund Spotlight: Lab-Grown Beta Cells Meet State-Of-The-Art Imaging To Answer New Questions About Type 1 Diabetes

BRI investigators Eddie James, PhD, and Caroline Stefani, PhD, are teaming up to take a unique approach to type 1 diabetes research.
Read Article
Blog Main Image - 3D Biological T Cells Attacking Cancer Cell
October 4, 2024

Allyson Byrd, PhD: Can Gut Bacteria Help Treat Cancer?

Why does a medicine work for one person, but not another with the same disease? Dr. Byrd is seeking answers in a place that some people might find surprising.
Read Article

Questions?

Contact us via email. We're happy to answer any questions you may have.